Drug Manufacturers - Specialty & Generic industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
93 of 151
P/E 18.1 vs period average 18.4 Near its historical average
Ranked among 30 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/30 | ![]() | $9.19 | 10.9 | 83 | 78 | 97 | 99 |
| 2/30 | ![]() | $25.36 | 70.4 | 74 | 73 | 89 | 97 |
| 3/30 | ![]() | $100.25 | 24.0 | 37 | 50 | 93 | 93 |
| 4/30 | ![]() | $70.19 | 15.3 | 89 | 97 | 89 | 92 |
| 5/30 | ![]() | $34.49 | 12.2 | 75 | 77 | 71 | 90 |
| 6/30 | ![]() | $5.86 | — | 99 | 30 | 88 | 86 |
| 7/30 | ![]() | $22.75 | 18.1 | 94 | 79 | 98 | 81 |
| 8/30 | ![]() | $37.09 | 60.8 | 26 | 47 | 81 | 78 |
| 9/30 | ![]() | $23.78 | 13.7 | 84 | 56 | 80 | 77 |
| 10/30 | ![]() | $23.16 | — | 30 | 47 | 69 | 75 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $10B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $21B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $3B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.2% | $43B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks